首页
订购/客服:400-666-5481

ACT-660602

    
≥98%

源叶(MedMol)
V46301 一键复制产品信息
1646267-59-5
C20H20F6N8OS
534.48
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
V46301-1mg
≥98%

¥2030.00

货期:3-5天 - - - -
V46301-5mg
≥98%

¥4490.00

货期:3-5天 - - - -
V46301-10mg
≥98%

¥7410.00

货期:3-5天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: ACT-660602 is an orally active antagonist of chemokine receptor (CXCR3) with an IC50 value of 204 nM. ACT-660602 inhibits T-cell migration and shows efficacy in acute lung ingury model. ACT-660602 can be used for autoimmune diseases research.
靶点: CXCR3:204 nM (IC50)
体内研究: ACT-660602 shows selectivity to CXCR3 over hERG, with IC50s of 18 μM (hERG).

ACT-660602 (112 nM; 6 h) inhibits cell migration and improves the metabolic stability.

ACT-660602 (5, 20, 100 or 500 nM) displays an non-competitive binding mode to CXCL10 and CXCL11 in different concentration, with more stable IC50s.
参考文献: 1. Meyer EA, et al. Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases. J Med Chem. 2022 Aug 10.
2. Caroff Eva, et al. Preparation of piperazinyltriazolylethanone derivatives for use as CXCR3 receptor modulators: World Intellectual Property Organization, WO2015011099. 2015-01-29.
保存条件: 2-8°C, 避光, 干燥
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.871 ml 9.355 ml 18.71 ml
5 mM 0.374 ml 1.871 ml 3.742 ml
10 mM 0.187 ml 0.935 ml 1.871 ml
50 mM 0.037 ml 0.187 ml 0.374 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×